Universalis, your very own breviary in pixels...

Wednesday 29 March 2017

A "Game-changer" for Eczema Sufferers? Still can't play....

I rejoice to hear of this, and I hope it brings many people back to the land of the living[normally].
U.S. regulators have approved the first powerful, injected medicine to treat serious cases of the skin condition eczema.
The Food and Drug Administration on Tuesday approved Dupixent (dupilumab) for moderate or severe eczema, which causes red, fiercely itchy rashes on the face, arms and legs.
In three studies of the drug including a total of 2,119 participants, one-third to two-thirds achieved clear or nearly clear skin. About 4 in 10 had itching decrease sharply, bringing better sleep and reducing anxiety and depression.
That said, it costs more annually than our household AGI, so there's that...

No comments: